Coordinated Corporate Communications
Malin invests in highly innovative life sciences companies and focuses on oncology, immunology and genetic diseases where innovative life science and healthcare technologies can deliver transformative treatments for patients.
We have been working with Malin since its initial listing in 2015, and have created and developed their corporate identity delivering a consistent visual style across all of its corporate communications collateral, from business cards to their annual reports.
Earlier this year following a Strategic Review in 2018, the Malin plc website was redesigned and developed by Source to reflect its renewed strategy and its focus on its priority assets.
We continue to work with Malin and its investee companies, developing visual communications for both print and digital media across a range of stakeholder engagement initiatives.